MAPT and Alzheimer disease: One of these tracers, 18F-AV1451, binds to tau aggregates in AD (Marquié et al., 2015), can differentiate AD patients from healthy controls (Schöll et al., 2016) and correlates with regional changes in brain metabolism in different clinical variants of AD (Ossenkoppele et al., 2016) (see poster).